Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Talquetamab for Multiple Myeloma
Recruiting1 awardPhase 1
Nashville, Tennessee
This trial tests Talquetamab, a new drug, in adults with multiple myeloma that has come back or didn't respond to other treatments. Doctors will monitor patients' health to see if the drug works and is safe.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service